Has Nathan Tiedeken, MD received payments from drug or device companies?

Yes. Drug and device makers reported $621 in general payments to Nathan Tiedeken, MD across 6 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Nathan Tiedeken, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Nathan Tiedeken, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Nathan Tiedeken, MD

Orthopaedic Surgery · West Reading, PANPI 1487965893

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $549 of the $621 with a category attached, or 88.4%. Smith+Nephew accounts for 93.2% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2019 at $579 and has fallen 95.7% since, to $25 in 2025. That places this record below the midpoint for orthopaedic surgery clinicians in PA, where the typical reported total is $3,243.

$621in general payments, 2019–2025

Across 6 payments — averaging $103.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Smith+Nephew$579
Novus Surgical Consultants$25
Amgen$17

What the payments were for

Travel & lodging$54988%
Food & beverage$7212%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Smith+Nephew	4	$579
Novus Surgical Consultants	1	$25
Amgen	1	$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$621 in reported general payments places this provider in the 25th percentile of 1,048 orthopaedic surgery providers in Pennsylvania.

See all orthopaedic surgery providers in Pennsylvania →

Medicare billing

Part B allowed, 2024

$412,638

Medicare patients

653

Services billed

21,130

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Diclofenac Sodium	18	$974
Celecoxib	21	$424
Tramadol Hcl	51	$213
Oxycodone Hcl	51	$210
Prednisone	102	$208
Meloxicam	43	$108
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim	20	$24

Paid to pharmacies, not to this prescriber.